Verici Dx plc (LON:VRCI – Get Free Report) shares rose 11.3% during trading on Tuesday . The stock traded as high as GBX 0.84 and last traded at GBX 0.84. Approximately 5,658,246 shares changed hands during trading, an increase of 176% from the average daily volume of 2,053,418 shares. The stock had previously closed at GBX 0.75.
Verici Dx Trading Up 19.7%
The company has a current ratio of 4.54, a quick ratio of 8.49 and a debt-to-equity ratio of 4.64. The company has a market cap of £13.59 million, a PE ratio of -0.31 and a beta of 1.59. The company has a fifty day simple moving average of GBX 0.74 and a two-hundred day simple moving average of GBX 0.81.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Stories
- Five stocks we like better than Verici Dx
- Large Cap Stock Definition and How to Invest
- 3 Signs Tesla Is Starting December on the Front Foot
- Why Invest in High-Yield Dividend Stocks?
- The Nuclear Revival Is Real: SMR Stocks Flash Buy Signals After DOE Push
- Dividend Capture Strategy: What You Need to Know
- Boeing’s Bullish Breakout: Is This Rally Cleared for Takeoff?
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
